window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Precision medicine

  • Artificial Intelligence,Biotech,Clinical Development,Diagnostics,Digital Health,Drug Development,Global health,Healthcare leadership,Precision medicine,Women's Health

    Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction

    Clairity, an AI-driven precision health company, has raised $43 million [...]

    November 13, 2025
  • Biotech,Cell & Gene Therapy,Clinical Development,Oncology,Precision medicine,Research & Development

    Inaphaea BioLabs boosts precision oncology with new partnerships, advanced tumour models, and digital patient avatars

    Inaphaea BioLabs, the translational contract research organisation (CRO) of ValiRx [...]

    September 26, 2025
  • Artificial Intelligence,Oncology,Precision medicine,Real world evidence,Research & Development,Women in Pharma

    Imagene AI and Sheba Medical Center form alliance to expand precision oncology with real-world data

    Imagene AI has expanded its collaboration with Sheba Medical Center [...]

    September 17, 2025
  • European biotech,Genomics and sequencing,Medical devices,Partnerships & Funding,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    Lithuania sets stage for Life Sciences Baltics with multi-billion-euro investments and AI innovation

    Lithuania’s life sciences sector is preparing to showcase its rapid [...]

    September 15, 2025
  • Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Precision medicine,Real world evidence

    Cemiplimab plus chemotherapy shows five-year survival benefit in advanced NSCLC Empower-lung 3 trial

    Regeneron UK Limited has reported five-year follow-up results from the [...]

    September 10, 2025
  • Clinical Trials,Drug Development,European biotech,Precision medicine

    DeuterOncology presents phase 1 data for do-2 MET inhibitor showing tumour control with low side effects

    DeuterOncology, a clinical-stage biotech company developing deuterated cancer therapies, has [...]

    September 10, 2025
  • Drug Development,Oncology,Partnerships & Funding,Precision medicine,Research & Development

    New glioblastoma treatment project secures funding from The Brain Tumour Charity

    Medicines Discovery Catapult (MDC) and King’s College London (KCL) have [...]

    September 9, 2025
  • Clinical Development,Clinical Trials,Pharmaceuticals and therapeutics,Precision medicine,Rare Diseases

    A potential first-in-class treatment for children with achondroplasia is now in clinical testing

    Tyra Biosciences has dosed the first child in BEACH301, its [...]

    August 22, 2025
  • Chronic diseases,Genomics and sequencing,Precision medicine,Research & Development

    Genomics and sequencing: Sapient study uses rLC-MS to map metabolic aging and disease insights in 26,000 samples

    Sapient has published a large-scale metabolomics study using its rapid [...]

    August 20, 2025
  • CDMOs & Manufacturing,Global health,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    Lungpacer receives CMS NTAP approval for AeroPace system, enhancing care for mechanically ventilated patients

    Lungpacer Medical has received CMS New Technology Add-on Payment approval [...]

    August 15, 2025
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion
    Categories: Drug discovery, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Precision medicine, Research & Development, Technology and platforms
  • Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow
    Categories: Biomanufacturing, CDMOs & Manufacturing, Drug Development, Manufacturing, Pharmaceuticals and therapeutics, Supply Chain & Logistics
  • Emalex wins US patent for ecopipam ODT as Tourette access program grows
    Categories: Clinical Development, Drug Development, FDA, Neurosciences, Pharmaceuticals and therapeutics, Rare Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top